HES Preparations Now Contraindicated in Patients with Severe Sepsis: Label Revisions

January 18, 2023
The Ministry of Health, Labor and Welfare (MHLW) on January 12 ordered label revisions to Fresenius Kabi Japan’s hydroxyethyl starch (HES) preparations, contraindicating their use in severe sepsis patients. The marketing authorizations for HES preparations for infusion, which are used...read more